Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Name : Leap Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.00000000000000
EPSttm :
finviz dynamic chart for LPTX

Float Short %

7.11

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.2

EPS Last/This Y

0.7

EPS This/Next Y

0.58

Price

2.05

Target Price

5.5

Analyst Recom

3

Performance Q

741.54

Relative Volume

219.54

Beta

0.09

Ticker: LPTX



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-10LPTX2.05N/AN/A0
2025-12-11LPTX2.05N/AN/A0
2025-12-12LPTX2.05N/AN/A0
2025-12-15LPTX2.05N/AN/A0
2025-12-16LPTX2.05N/AN/A0
2025-12-17LPTX2.05N/AN/A0
2025-12-18LPTX2.05N/AN/A0
2025-12-19LPTX2.05N/AN/A0
2025-12-22LPTX2.05N/AN/A0
2025-12-23LPTX2.05N/AN/A0
2025-12-26LPTX2.05N/AN/A0
2025-12-29LPTX2.05N/AN/A0
2025-12-30LPTX2.05N/AN/A0
2025-12-31LPTX2.05N/AN/A0
2026-01-02LPTX2.05N/AN/A0
2026-01-05LPTX2.05N/AN/A0
2026-01-06LPTX2.05N/AN/A0
2026-01-07LPTX2.05N/AN/A0
2026-01-08LPTX2.05N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



No data found



No data found

Last Quarter Act. EPS​

-0.4

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.2

Insider Transactions

Institutional Transactions

-5.11

Beta

0.09

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

19

Sentiment Score

88

Actual DrawDown %

95.1

Max Drawdown 5-Year %

-99.4

Target Price

5.5

P/E

Forward P/E

PEG

P/S

P/B

14.86

P/Free Cash Flow

EPS

-1.59

Average EPS Est. Cur. Y​

-1.11

EPS Next Y. (Est.)

-0.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

219.54

Return on Equity vs Sector %

-1175.7

Return on Equity vs Industry %

-1160.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.15

EBIT Estimation

Leap Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 52
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.
stock quote shares LPTX – Leap Therapeutics Inc Stock Price stock today
news today LPTX – Leap Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch LPTX – Leap Therapeutics Inc yahoo finance google finance
stock history LPTX – Leap Therapeutics Inc invest stock market
stock prices LPTX premarket after hours
ticker LPTX fair value insiders trading